This Article Full Text Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by SoRelle, R. Search for Related Content PubMed PubMed Citation Articles by SoRelle, R.

(Circulation. 2004;109:e9031-e9032.)
© 2004 American Heart Association, Inc.

Cardiovascular News

Ruth SoRelle, MPH

Circulation Newswriter

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Implantable Defibrillators Help Patients With Arrhythmogenic Right Ventricular Cardiomyopathy but. . .

Implantation of cardioverter-defibrillators in high-risk patients with arrhythmogenic right ventricular cardiomyopathy benefits them, according to a report in the present issue of Circulation ( Circulation. 2004;109:1503–1508[Abstract/Free Full Text]). A high risk of disease progression or lead-related morbidity requires careful placement and long-term observation of the necessary transvenous lead performance, said researchers from the University Hospital of Münster and Institute for Arteriosclerosis Research at the University of Münster in Germany.

In this single-center study led by Thomas Wichter, MD, 60 patients with arrhythmogenic right ventricular cardiomyopathy received transvenous implantable cardioverter-defibrillator systems. Lower R-wave amplitudes were achieved in these patients compared with others chosen as controls, although more right ventricular sites were tested for adequate lead positions. At 1, 3, 5, and 7 years, the implantable cardioverter-defibrillator showed an advantage for the patients treated. However, 53 adverse events occurred in 37 patients during the period immediately after treatment or during follow-up.

Ten Honored at American College of Cardiology Scientific Sessions
NEW ORLEANS, La—Ten cardiovascular physicians were honored at the American College of Cardiology (ACC) Scientific Sessions 2004 for outstanding achievements and contributions to the organization. Those honored included:

Joseph S. Alpert, MD
Joseph S. Alpert, MD, Professor of Medicine and Chair of the Department of Medicine at the University of Arizona Health Sciences Center in Tucson, accepted the ACC Gifted Teacher Award. Dr Alpert has mentored and supervised countless fellows in cardiology, many of whom have gone on to distinguish themselves as directors or chairs of divisions of cardiology. He continues to set teaching standards as a member of the ACC Publications Committee and the . . . [Full Text of this Article]